Skip to main content

Table 3 Characteristics of blood streams infections in newly diagnosed myeloma patients

From: Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma

Serial number

BSI after ICT

ICT regimen

Catheter type

Definite CRIb

Pathogen

Empirical antibiotics

Early death

(< 100day)

Nosocomial BSIa

 1 (90)

-

-

-

-

Coagulase-negative Staphylococcus species

Ceftazidime/isepamicin

Y

 2 (215)

Y

Thalidomide/dexamethasone

-

-

Coagulase-negative Staphylococcus species

Ceftazidime

-

 3 (79)

Y

VAD

Implanted port

Y

Coagulase-negative Staphylococcus species

Klebsiella pneumoniae

Teicoplanin/isepamicin

Y

 4 (27)

-

MP

-

-

Klebsiella pneumoniae

Cefepime

-

 5 (62)

Y

MPT

Non-tunneled CVC

Y

Klebsiella pneumoniae

Ciprofloxacin

- > Imipenem/teicoplanin

Y

 6 (78)

-

-

-

-

Escherichia coli

 

Y

 7 (198)

Y

VAD

Non-tunneled CVC

-

Escherichia coli

Cefuroxime/clindamycin

Y

 8 (168)

Y

VAD/thalidomide

Non-tunneled PICC

-

Escherichia coli

Imipenem/vancomycin/amikin

Y

 9 (175)

Y

VAD

-

-

Escherichia coli

Cefuroxime/metronidazole

-

 10 (150)

Y

VAD

-

-

Enterobacter gergoviae

Oxacillin

-

 11 (14)

Y

VAD

Implanted port

-

Enterobacter cloacae

 

-

 12 (94)

-

VAD

Non-tunneled CVC

-

Pseudomonas Aeruginosa

Cefepime

Y

 13 (115)

Y

VAD

Implanted port

-

Proteus mirabilis

Levofloxacin

-

 14 (69)

Y

VAD

-

-

Salmonella Enteritidis group D

Ceftazidime

Y

 15 (114)

Y

VAD

Non-tunneled CVC

-

Staphylococcus aureus

 

-

 16 (71)

-

-

Non-tunneled CVC

Y

Serratia marcescens

 

Y

 17 (61)

Y

MP

Non-tunneled CVC

-

Yeast like-Trichosporon asahii

Cefepime/azithromycin

Y

 18 (18)

Y

VAD

-

-

Yeast like-Candida albicans

Ceftazidime/teicoplanin

Y

Non-nosocomial BSI

 1 (221)

-

-

-

-

Coagulase-negative Staphylococcus species

Flomoxef

-

 2 (41)

Y

VAD

-

-

Coagulase-negative Staphylococcus species

Piperacillin/tazobactam

-

 3 (211)

Y

MP

-

-

Coagulase-negative Staphylococcus species

 

-

 4 (205)

-

-

-

-

Streptococcus

Meropenem/vancomycin/metronidazole

Y

 5 (137)

-

-

-

-

Streptococcus pneumoniae

 

-

 6 (6)

-

MP

-

-

Escherichia coli

Cephalexin/isepamicin

-

 7 (106)

-

VAD

Non-tunneled CVC

-

Pseudomonas aeruginosa

Cefoperazone

-

 8 (46)

Y

MP

Tunneled CVC

(Permcath)

-

Lactobacillus species

Moxifloxacin

Y

  1. Abbreviations: BSI Blood stream infection, ICT Induction chemotherapy, CRI Catheter related infection, VAD Vincristine/doxorubicin/dexamethasone, MP Melphalan/prednisolone, MPT Melphalan/prednisolone/thalidomide, CVC Central venous catheter, PICC Peripherally inserted central catheter
  2. aNosocomial infection is defined as infection become evident 48 h or more after admission
  3. bDefinite CRI (catheter related infection) is defined as bacteremia/fungemia in a patient with an intravascular catheter with at least one positive blood culture obtained from a peripheral vein, clinical manifestations of infection (i.e., fever, chills, and/or hypotension), and no apparent source for the bloodstream infection except the catheter